NCT07647510 clinical trial report covering Claseprubart, Phase 3, endpoints, sponsor, geography, readout timing and development white space.

NCT07717411 clinical trial report covering Trontinemab, Phase 3, endpoints, sponsor, geography, readout timing and development white space.

CTR20262350 clinical trial report covering Herpes zoster mRNA vaccine(Suzhou Abogen), Phase 3, endpoints, sponsor, geography, readout timing and developmen

NCT07647328 clinical trial report covering Camizestrant, Phase 3, endpoints, sponsor, geography, readout timing and development white space.

A Biology Modality MCP review of S1PR1 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.

A Biology Modality MCP review of PDGFD protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.

A Biology Modality MCP review of PDGFC protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.

A Biology Modality MCP review of PDGFB protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.

A Biology Modality MCP review of PDGFA protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.

A Biology Modality MCP review of P2RY8 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.

A Biology Modality MCP review of MMP28 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.

A Biology Modality MCP review of MMP27 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.